CLOS
ENZY

Compagnie Lombard Odier SCmA’s Enzymotec Ltd ENZY Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,000
Closed -$26K – 885
2016
Q4 		$26K Hold
4,000
– – ﹤0.01% 680
2016
Q3 		$28K Hold
4,000
– – ﹤0.01% 756
2016
Q2 		$33K Hold
4,000
– – ﹤0.01% 724
2016
Q1 		$36K Buy
+4,000
New +$34.9K ﹤0.01% 762

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ENZY Position: Q1 2017 in Review

Compagnie Lombard Odier SCmA sold out of Enzymotec Ltd (ENZY) in Q1 2017, closing a stake of 4,000 shares — an estimated $26K sold.

Compagnie Lombard Odier SCmA first reported a position in ENZY in Q1 2016 and held it in 4 quarters. The position peaked at $36K in Q1 2016. 26 funds tracked by Wall St. Rank hold ENZY as of Q1 2017.

  • Compagnie Lombard Odier SCmA reported no remaining Enzymotec Ltd position as of Q1 2017 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 4,000 Enzymotec Ltd shares in Q1 2017, an estimated $26K.
  • Compagnie Lombard Odier SCmA first reported a position in Enzymotec Ltd in Q1 2016 and held it in 4 quarters.
  • Compagnie Lombard Odier SCmA's Enzymotec Ltd position peaked at $36K in Q1 2016.
  • 26 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2017.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2017, filed 15 May 2017.